Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ian Sutton
133 B Cell Depletion Therapy Resulting in Sustained Remission of Severe Autoimmune Complications Following Alemtuzumab Treatment of Multiple Sclerosis
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Related publications
A Case of Autoimmune Myositis After Treatment With Alemtuzumab for Multiple Sclerosis
Multiple Sclerosis Journal - Experimental, Translational and Clinical
Immune Competence After Alemtuzumab Treatment of Multiple Sclerosis
Neurology
Neurology
Alemtuzumab Following Natalizumab in Highly Active Paediatric-Onset Multiple Sclerosis
Multiple Sclerosis Journal - Experimental, Translational and Clinical
Differential Reconstitution of T Cell Subsets Following Immunodepleting Treatment With Alemtuzumab (Anti-Cd52 Monoclonal Antibody) in Patients With Relapsing-Remitting Multiple Sclerosis
Journal of Immunology
Allergy
Immunology
Adverse Events With Fatal Outcome Associated With Alemtuzumab Treatment in Multiple Sclerosis
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Comparative Efficacy of Alemtuzumab And established Treatment in the Management Of multiple Sclerosis
Neuropsychiatric Disease and Treatment
Alemtuzumab: A Review of Efficacy and Risks in the Treatment of Relapsing Remitting Multiple Sclerosis
Therapeutics and Clinical Risk Management
AB0458 B Cells Depletion for the Treatment of Systemic Autoimmune Diseases
Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
